QLGN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system...

Stats
Today's Volume	231 185
Average Volume	68 000.00
Market Cap	1.90M
EPS	$-0.640 ( 2023-11-14 )
Next earnings date	( $-0.520 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.00600 (1.99%)

Insider Trading

Date	Person	Action	Amount	type
2022-07-11	Abdul-ahad Wajdi	Buy	80 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Arshad Tariq	Buy	102 000	Stock Option (Right to Buy)
2022-07-11	Ritter Ira E.	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 8 588 032 \| Sell: 1 076 061

Volume Correlation

Long: 0.25 (neutral)

Short: -0.34 (neutral)

Signal:(44.107) Neutral

Qualigen Therapeutics Inc Correlation

10 Most Positive Correlations
LYEL	0.959
ARQQ	0.958
FATE	0.954
RPID	0.953
NKTX	0.951
STRC	0.951
LYRA	0.945
GROM	0.944
LUMO	0.943
KBSF	0.943

10 Most Negative Correlations
FRSG	-0.964
AHRN	-0.957
LRFC	-0.955
FRONU	-0.955
NWFL	-0.954
LEGA	-0.952
TBSA	-0.951
ACQR	-0.95
AVAC	-0.949
PTOC	-0.948

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Qualigen Therapeutics Inc Correlation - Currency/Commodity

-0.66
( moderate negative )

-0.63
( weak negative )

0.00
( neutral )

-0.62
( weak negative )

0.00
( neutral )

0.67
( moderate )

Qualigen Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2023
Revenue:	$0
Gross Profit:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2022
Revenue:	$4.98M
Gross Profit:	$680 801 (13.66 %)
EPS:	$-5.48

FY	2021
Revenue:	$5.65M
Gross Profit:	$1.32M (23.37 %)
EPS:	$-6.10

Financial Reports:

No articles found.

Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Realtime updates for Qualigen Therapeutics Inc [QLGN]

Upcoming Earnings Alert